Great Basin Scientific to Present at the 2nd Annual Growth Capital Expo

SALT LAKE CITY, April 6, 2015 /PRNewswire/ -- Great Basin Scientific, Inc. (NASDAQ: GBSN), a molecular diagnostics company, announced today that co-founder and CEO Ryan Ashton will present at the 2nd Annual Growth Capital Expo at 2:00 p.m. PDT April 13 at Caesars Palace in Las Vegas, NV. Management will also be available for investor meetings on April 13 and 14.

A live webcast of this presentation can be accessed at http://wsw.com/webcast/gce2/gbsn and will be archived after the presentation for 90 days via this same link.

About Great Basin Scientific
Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The Company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. The Company's vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. More information can be found on the company's website at www.gbscience.com

Media Contact: 
Tony Russo, Ph.D. or Todd Davenport, Ph.D. 
Russo Partners, LLC 
212.845.4251
212.845.4235
[email protected] 
[email protected]

Investor Relations Contact:
Bob Yedid 
ICR
646.277.1250
[email protected] 

SOURCE Great Basin Scientific, Inc.

Related Links

http://www.gbscience.com